Climacteric

Editorial policy

Sources & Editorial Policy

The evidence behind this guide, and how each page is reviewed.

Principal sources

  1. Davis SR, Taylor S, Hemachandra C, et al. The 2023 Practitioner's Toolkit for Managing Menopause. Climacteric. 2023;26(6):517–536.
  2. Women's Health Initiative (WHI) randomized trials of menopausal hormone therapy.
  3. NORA (National Osteoporosis Risk Assessment) study.
  4. U.S. Food and Drug Administration prescribing information for fezolinetant (Veozah, 2023) and elinzanetant (Lynkuet, 2025).
  5. U.S. Food and Drug Administration. HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. Press announcement, November 10, 2025.

Review and dating

Pages are reviewed by a physician for clinical accuracy and dated so readers can see when the evidence was last assessed. We update content when major professional guidance or relevant treatment information changes.